NASDAQ:SILK - Silk Road Medical Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $63.75
  • Forecasted Upside: 3.01 %
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$61.89
▼ -0.36 (-0.58%)
1 month | 3 months | 12 months
Get New Silk Road Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SILK and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SILK

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$63.75
▲ +3.01% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Silk Road Medical in the last 3 months. The average price target is $63.75, with a high forecast of $75.00 and a low forecast of $54.00. The average price target represents a 3.01% upside from the last price of $61.89.
Buy
The current consensus among 4 polled investment analysts is to buy stock in Silk Road Medical.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/3/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/1/2019
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/30/2019
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
1/28/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
4/27/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
7/26/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
9/24/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/24/2020

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/12/2020SVB LeerinkBoost Price TargetOutperform$60.00 ➝ $75.00Low
i
Rating by D. Antalffy at SVB Leerink LLC
10/1/2020CitigroupDowngradeBuy ➝ Neutral$58.00 ➝ $71.00High
i
8/21/2020Piper SandlerInitiated CoverageNeutral$54.00High
i
8/6/2020Stifel NicolausBoost Price TargetBuy$47.00 ➝ $55.00High
i
Rating by Rick Wise at Stifel Nicolaus
8/6/2020SVB LeerinkBoost Price TargetOutperform$51.00 ➝ $60.00Medium
i
Rating by D. Antalffy at SVB Leerink LLC
8/6/2020CitigroupBoost Price TargetBuy$50.00 ➝ $58.00Medium
i
7/9/2020SVB LeerinkInitiated CoverageOutperform$51.00High
i
Rating by D. Antalffy at SVB Leerink LLC
7/1/2020Stifel NicolausReiterated RatingBuy$47.00Low
i
Rating by Rick Wise at Stifel Nicolaus
5/27/2020CitigroupInitiated CoverageBuy$50.00High
i
5/1/2020Stifel NicolausBoost Price TargetBuy$37.00 ➝ $47.00Low
i
2/27/2020Stifel NicolausBoost Price TargetBuy$49.00 ➝ $51.00High
i
8/20/2019ArgusInitiated CoverageBuy$52.00 ➝ $52.00Low
i
4/29/2019Bank of AmericaInitiated CoverageNeutral ➝ Neutral$43.00Medium
i
4/29/2019JPMorgan Chase & Co.Initiated CoverageOverweight ➝ Overweight$45.00Low
i
4/29/2019Stifel NicolausInitiated CoverageBuy ➝ Buy$44.00Low
i
4/29/2019BMO Capital MarketsInitiated CoverageOutperform ➝ Outperform$40.01Low
i
(Data available from 10/24/2015 forward)
Silk Road Medical logo
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products includes ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent with clinical data regarding lasting safety outcomes; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was founded in 2007 and is headquartered in Sunnyvale, California.
Read More

Today's Range

Now: $61.89
$61.00
$63.36

50 Day Range

MA: $64.86
$57.83
$69.61

52 Week Range

Now: $61.89
$20.84
$72.19

Volume

160,371 shs

Average Volume

286,172 shs

Market Capitalization

$2.08 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.7